Cargando…
The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population
BACKGROUND: Periodic surveillance of the hepatitis C virus (HCV) care cascade is important for tracking progress toward HCV elimination goals, identifying gaps in care, and prioritizing resource allocation. In the pre-direct-acting antiviral (DAA) era, it was estimated that 50% of HCV-infected indiv...
Autores principales: | Ferrante, Nicole D, Newcomb, Craig W, Forde, Kimberly A, Leonard, Charles E, Torgersen, Jessie, Linas, Benjamin P, Rowan, Sarah E, Wyles, David L, Kostman, Jay, Trooskin, Stacey B, Lo Re, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454032/ https://www.ncbi.nlm.nih.gov/pubmed/36092829 http://dx.doi.org/10.1093/ofid/ofac445 |
Ejemplares similares
-
Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study
por: Gowda, Charitha, et al.
Publicado: (2018) -
Re-treatment of Hepatitis C Infection After Multiple Failures of Direct-Acting Antiviral Therapy
por: Fierer, Daniel S, et al.
Publicado: (2020) -
Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study
por: Brooks, Kristina M, et al.
Publicado: (2020) -
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status
por: Gowda, Charitha, et al.
Publicado: (2017) -
Association Between Rotavirus Vaccination and Antibiotic Prescribing Among Commercially Insured US Children, 2007–2018
por: Hall, Eric W, et al.
Publicado: (2022)